Search Result "T315I mutation"
Inhibitors of ABL and the ABL-T315I Mutation
Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 905-921
Author(s): Glenn Noronha, Jianguo Cao, Chun P. Chow, Elena Dneprovskaia, Richard M. Fine, John Hood, Xinshan Kang, Boris Klebansky, Dan Lohse, Chi Ching Mak, Andrew McPherson, Moorthy S.S. Palanki, Ved P. Pathak, Joel Renick, Richard Soll, Binqi Zeng
Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2146-2157
Author(s): X. Y. Lu, Q. Cai, K. Ding
Screening and Activity Evaluation of Novel BCR-ABL/T315I TyrosineKinase Inhibitors
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 20 Year: 2024 Page: 2872-2894
Author(s):
Mutation Analysis of ABL1 Gene and its Relation to the Achievement of Major Molecular Response in Indonesian Chronic Myeloid Leukemia Patients
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 17 Issue: 1 Year: 2020 Page: 48-54
Author(s): Reni Widyastuti,Melva Louisa,Ikhwan Rinaldi,Riki Nova,Instiaty Instiaty,Rizky Priambodo
Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 3 Year: 2006 Page: 347-355
Author(s): Shinya Kimura
Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Shinya Kimura
Doi: 10.2174/978160805161811001010116
New Opportunities to Treat the T315I-Bcr-Abl Mutant in Chronic Myeloid Leukaemia: Tyrosine Kinase Inhibitors and Molecules that Act by Alternative Mechanisms
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 1220-1245
Author(s): S. Schenone, C. Brullo, M. Botta
Targeting Drug Resistant Mutations Using Novel Binding Interactions â Lessons Learned from Abl-T315I and their Implications in Drug Design
Ebook: Frontiers in Drug Design and Discovery
Volume: 3 Year: 2007
Author(s): Glen Noronha,Jianguo Cao,Chun Chow,Elena Dneprovskaia,Linda Hwang,Dan Lohse,Chi Ching Mak,Andrew McPherson,Richard M. Fine,Xinshan Kang,Boris Klebansky,Moorthy S.S. Palanki,Ved P. Pathak,Joel Renick,Richard Soll,Binqi Zeng
Doi: 10.2174/978160805201110703010121
Ponatinib: A Review of Efficacy and Safety
Journal: Current Cancer Drug Targets
Volume: 18 Issue: 9 Year: 2018 Page: 847-856
Author(s): Fulvio Massaro,Matteo Molica,Massimo Breccia
In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 3 Year: 2011 Page: 396-404
Author(s): R. Rajasekaran, C. George Priya Doss, G. Arun Prasad, Rao Sethumadhavan